News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,453 Results
Type
Article (1938)
Company Profile (2)
Press Release (67513)
Section
Business (21529)
Career Advice (9)
Deals (4573)
Drug Development (8218)
FDA (1813)
Job Trends (802)
News (37167)
Policy (3573)
Tag
Academia (91)
Alliances (8121)
Alzheimer's disease (118)
Antibody-drug conjugate (ADC) (7)
Approvals (1825)
Artificial intelligence (8)
Bankruptcy (9)
Best Places to Work (583)
Biosimilars (13)
Breast cancer (13)
Cancer (154)
Career advice (9)
Cell therapy (14)
Clinical research (6979)
Collaboration (58)
COVID-19 (181)
C-suite (7)
Data (134)
Diabetes (10)
Diagnostics (590)
Drug discovery (12)
Duchenne muscular dystrophy (7)
Earnings (7536)
Events (6929)
Executive appointments (37)
FDA (1903)
Funding (38)
Gene therapy (14)
GLP-1 (40)
Government (234)
Healthcare (1084)
Infectious disease (185)
Inflammatory bowel disease (14)
Intellectual property (7)
IPO (1635)
Job creations (240)
Job search strategy (9)
Layoffs (7)
Legal (945)
Liver cancer (16)
Lung cancer (28)
Lymphoma (8)
Manufacturing (23)
Medical device (1115)
Medtech (1116)
Mergers & acquisitions (3002)
Metabolic disorders (29)
Neuroscience (149)
NextGen: Class of 2025 (220)
Non-profit (62)
Northern California (109)
Obesity (12)
Ovarian cancer (7)
Pancreatic cancer (7)
Parkinson's disease (12)
Patents (11)
People (4949)
Phase I (1885)
Phase II (2911)
Phase III (2670)
Pipeline (58)
Postmarket research (241)
Preclinical (655)
Radiopharmaceuticals (22)
Rare diseases (19)
Real estate (599)
Regulatory (2551)
Reports (6)
Research institute (93)
Schizophrenia (6)
Series A (11)
Southern California (98)
Startups (422)
Supply chain (6)
United States (914)
Vaccines (20)
Date
Today (3)
Last 7 days (43)
Last 30 days (156)
Last 365 days (3223)
2025 (118)
2024 (3275)
2023 (3826)
2022 (7026)
2021 (6387)
2020 (5892)
2019 (3892)
2018 (3029)
2017 (3604)
2016 (3219)
2015 (4055)
2014 (3022)
2013 (2602)
2012 (2775)
2011 (2903)
2010 (2663)
Location
Africa (79)
Asia (21213)
Australia (2419)
California (239)
Canada (178)
China (117)
Connecticut (11)
Europe (12434)
Florida (14)
Illinois (15)
Japan (48)
Maryland (65)
Massachusetts (174)
Minnesota (23)
New Jersey (123)
New York (102)
North Carolina (50)
Northern California (109)
Pennsylvania (33)
South America (105)
Southern California (98)
Texas (15)
Utah (7)
Virginia (13)
69,453 Results for "novocure ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
November 21, 2024
·
6 min read
Press Releases
Novocure to Participate in Upcoming Investor Conferences
November 27, 2024
·
2 min read
Press Releases
Novocure to Report Second Quarter 2024 Financial Results
Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial markets open.
July 1, 2024
·
3 min read
Press Releases
Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference
January 3, 2025
·
2 min read
Press Releases
Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update
January 13, 2025
·
13 min read
Business
Novocure Reports First Quarter 2024 Financial Results
Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended March 31, 2024.
May 2, 2024
·
10 min read
FDA
FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer
October 15, 2024
·
11 min read
Press Releases
Novocure Appoints Christoph Brackmann as Chief Financial Officer
October 30, 2024
·
4 min read
Press Releases
Novocure Reports Third Quarter 2024 Financial Results
October 30, 2024
·
11 min read
Press Releases
Novocure to Report Third Quarter 2024 Financial Results
October 1, 2024
·
3 min read
1 of 6,946
Next
